Developing novel technology for mapping dynamic oncoprotein interaction networks
开发绘制动态癌蛋白相互作用网络的新技术
基本信息
- 批准号:8538899
- 负责人:
- 金额:$ 22.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAffinity ChromatographyAllelesAntibodiesAntibody FormationAssesCancer cell lineCell NucleusCellsComplexCytosolDNADetectionDevelopmentEctopic ExpressionEnvironmentEpidermal Growth Factor ReceptorEpitopesFeedbackGenesGenetic TranscriptionGoalsHumanKnock-in MouseKnock-outKnowledgeLeadLightMADH4 geneMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMethodsModelingMolecularMutationOncogene ProteinsOncogenicPIK3CA genePhysiologicalProtein DynamicsProteinsProteolytic ProcessingProteomicsReagentRecombinant ProteinsRequest for ProposalsRoleSTAT3 geneSensitivity and SpecificitySet proteinSignal TransductionSpecificityStimulusTP53 geneTechniquesTechnologyTestingThe Cancer Genome AtlasTherapeuticTimeTumor Suppressor GenesWorkcancer cellcell typeexperienceextracellulargain of function mutationgene functionhomologous recombinationinnovationmutantnew technologynew therapeutic targetnotch proteinnovelnovel strategiesprotein complexprotein expressionprotein protein interactionpublic health relevanceresponsetechnology developmenttumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Many oncoproteins and tumor suppressive proteins shuttle between the cytosol and nucleus and thus interact with changing sets of protein partners in different sub-cellular compartments. Furthermore, increasing evidence indicates that oncogenic mutations of these proteins can result in alteration of cellular localization and rewirin of oncoprotein interaction networks. Characterization of the dynamic interaction network of oncoproteins and tumor suppressive proteins is therefore crucial to understand their roles in tumorigenesis. Robust technologies for mapping dynamic protein interaction networks under physiological conditions within the cell are not yet available. We propose to develop a novel approach for mapping dynamic oncoprotein interaction networks using endogenously epitope-tagged proteins for affinity- purification and quantitative proteomics for accurate network identification. This application builds upon our successful development of an innovative method to introduce epitope tag- encoding DNA into endogenous loci by homologous recombination-mediated knock-in in human cancer cells and our intensive experience in quantitative proteomics analysis. The endogenously tagged proteins are expressed at physiological levels and provide physiologically-relevant environments and compartments for protein complex identification and are therefore ideal for mapping dynamic protein networks. The goals of this application are twofold. First, we propose a detailed quantitative comparison of our technique in terms of distinguishing mutant and wild-type oncoprotein complexes against two conventional approaches for studying protein complexes. Second we test the potential of our new approach for studying the dynamic interactions that occur in response to cell signaling. Successful development of this technology will provide a platform for understanding the reconfigurations to protein interaction networks that result from oncogenic related translocation or mutation. As large-scale projects such as The Cancer Genome Atlas (TCGA) proceed, many more novel oncogenes and tumor suppressor genes will be discovered; our technology provides an important pipeline for understanding the function of these genes at the interaction network level by mapping their dynamic interaction networks.
描述(申请人提供):许多癌蛋白和肿瘤抑制蛋白在胞浆和细胞核之间穿梭,从而与不同亚细胞隔间中不断变化的蛋白质配对相互作用。此外,越来越多的证据表明,这些蛋白的致癌突变可以导致细胞定位的改变和癌蛋白相互作用网络的重排。因此,表征癌蛋白和肿瘤抑制蛋白的动态相互作用网络对于理解它们在肿瘤发生中的作用至关重要。目前还没有在细胞内生理条件下绘制动态蛋白质相互作用网络图的可靠技术。我们建议开发一种新的方法来绘制动态的癌蛋白相互作用网络图,使用内源性表位标记的蛋白质进行亲和纯化,并利用定量蛋白质组学来准确识别网络。这一应用建立在我们成功地开发了一种创新的方法,通过同源重组介导的敲入将表位标签编码的DNA引入到人类癌细胞的内源基因座中,以及我们在定量蛋白质组学分析方面的丰富经验。内源性标记的蛋白质在生理水平上表达,并为蛋白质复合体鉴定提供与生理相关的环境和隔间,因此是绘制动态蛋白质网络的理想选择。这个应用程序的目标有两个。首先,我们提出了我们的技术在区分突变和野生型癌蛋白复合体方面与两种研究蛋白质复合体的传统方法进行了详细的定量比较。其次,我们测试了我们的新方法在研究细胞信号反应中发生的动态相互作用的潜力。这项技术的成功开发将为理解致癌相关易位或突变导致的蛋白质相互作用网络的重新配置提供一个平台。随着大规模项目的进行,如癌症基因组图谱(TCGA),将发现更多新的癌基因和肿瘤抑制基因;我们的技术通过绘制这些基因的动态相互作用网络图,为在相互作用网络水平上了解它们的功能提供了一条重要的管道。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhenghe Wang其他文献
Zhenghe Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhenghe Wang', 18)}}的其他基金
Role of PTPRT in colon cancer progression and metastasis
PTPRT 在结肠癌进展和转移中的作用
- 批准号:
10527892 - 财政年份:2022
- 资助金额:
$ 22.47万 - 项目类别:
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis
PIK3CA螺旋结构域突变驱动结直肠肿瘤发生的机制
- 批准号:
10671633 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis
PIK3CA螺旋结构域突变驱动结直肠肿瘤发生的机制
- 批准号:
10463781 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Role of Erbb3 kinase activity in colorectal tumorigenesis.
Erbb3 激酶活性在结直肠肿瘤发生中的作用。
- 批准号:
10329986 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Role of Erbb3 kinase activity in colorectal tumorigenesis.
Erbb3 激酶活性在结直肠肿瘤发生中的作用。
- 批准号:
10549861 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis
PIK3CA螺旋结构域突变驱动结直肠肿瘤发生的机制
- 批准号:
10301099 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Next-generation mouse gene-targeting technology to model tumorigenesis
下一代小鼠基因靶向技术模拟肿瘤发生
- 批准号:
8621211 - 财政年份:2013
- 资助金额:
$ 22.47万 - 项目类别:
Developing novel technology for mapping dynamic oncoprotein interaction networks
开发绘制动态癌蛋白相互作用网络的新技术
- 批准号:
8432550 - 财政年份:2012
- 资助金额:
$ 22.47万 - 项目类别:
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations
项目 4:针对携带 PIK3CA 突变的结直肠癌中的谷氨酰胺代谢
- 批准号:
10227755 - 财政年份:2011
- 资助金额:
$ 22.47万 - 项目类别:
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT
受体酪氨酸磷酸酶PTPRT抑制结肠癌的机制
- 批准号:
8125027 - 财政年份:2007
- 资助金额:
$ 22.47万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 22.47万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 22.47万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 22.47万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 22.47万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 22.47万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 22.47万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 22.47万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 22.47万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




